ReviewFrontiers in pediatrics2025
Research progress on microecology and childhood respiratory infections via the lung-gut axis.
Review in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Respiratory tract infections (RTIs) are a complex global public health challenge, with children being the most affected population. Affected children often exhibit gut microbiota-related symptoms, such as dysbiosis, feeding difficulties, and malabsorption. Studies show that the lungs and large intestine share embryological homology and a mucosal immune system, with gut microbiota influencing respiratory health-a phenomenon termed the "lunggut axis" Gut dysbiosis may disrupt respiratory microbiota homeostasis, elevating susceptibility to respiratory infections. Probiotic administration mitigates gut dysbiosis and antibiotic resistance induced by antibiotic overuse. It can also restore the balance of gut microbiota, enhance the immune response and metabolic regulation, and thus prevent and assist in treating respiratory infections and other respiratory diseases. A deeper understanding of the relationship between the lung-gut axis microecology and respiratory infections in children may provide novel insights and approaches for disease prevention, diagnosis, and treatment. This review will describe the normal microecology of the respiratory tract in children, the microecological changes associated with respiratory tract infections in children, and the interactions between the "lung-gut axis" and the use of probiotics. It will also provide an outlook on these topics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.